Literature DB >> 21719524

Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats.

Masanobu Yamazato1, Anderson J Ferreira, Yoriko Yamazato, Carlos Diez-Freire, Lihui Yuan, Robert Gillies, Mohan K Raizada.   

Abstract

The renin-angiotensin system (RAS) in the nucleus tractus solitarius (NTS) is an important modulator of the baroreceptor heart rate reflex. This study tested the hypothesis that angiotensin-converting enzyme 2 (ACE2) expression is decreased in the NTS of spontaneously hypertensive rats (SHRs) and that its gene transfer in this nucleus would lead to beneficial effects on baroreflex function since this enzyme is key in the regulation of the vasoprotective axis of the RAS. ACE2 protein levels and its activity were significantly decreased in the NTS of SHRs compared to normotensive Wistar-Kyoto (WKY) control rats. Rats instrumented with radio-telemetry transducers received NTS microinjection of either Lenti-ACE2 (Lentiviral vector-mediated gene transfer of ACE2) or lenti-GFP (green fluorescent protein). The ACE2 gene transfer into the NTS resulted in long-term overexpression of ACE2. This was associated with a 60% increase in heart rate baroreflex sensitivity in the lenti-ACE2 injected SHRs compared with the lenti-GFP injected control SHRs (0.27 ± 0.02 ms/mmHg in lenti-GFP rats vs. 0.44 ± 0.07 ms/mmHg in lenti-ACE2 rats). These observations demonstrate that ACE2 gene transfer overcomes its intrinsic decrease in the NTS of SHRs and improves baroreceptor heart rate reflex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21719524      PMCID: PMC3375591          DOI: 10.1177/1470320311412809

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  21 in total

1.  Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system.

Authors:  Marc F Doobay; Lauren S Talman; Teresa D Obr; Xin Tian; Robin L Davisson; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-08-31       Impact factor: 3.619

2.  Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.

Authors:  Matthew J Huentelman; Justin L Grobe; Jorge Vazquez; Jillian M Stewart; Adam P Mecca; Michael J Katovich; Carlos M Ferrario; Mohan K Raizada
Journal:  Exp Physiol       Date:  2005-07-27       Impact factor: 2.969

3.  ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR.

Authors:  Carlos Díez-Freire; Jorge Vázquez; María F Correa de Adjounian; Merari F R Ferrari; Lihui Yuan; Xeve Silver; Raquel Torres; Mohan K Raizada
Journal:  Physiol Genomics       Date:  2006-06-20       Impact factor: 3.107

Review 4.  Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease.

Authors:  Julie R Ingelfinger
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

5.  Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats.

Authors:  Debra I Diz; Maria A Garcia-Espinosa; Stephen Gegick; Ellen N Tommasi; Carlos M Ferrario; E Ann Tallant; Mark C Chappell; Patricia E Gallagher
Journal:  Exp Physiol       Date:  2008-03-20       Impact factor: 2.969

6.  Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain.

Authors:  Lenice K Becker; Gisele M Etelvino; Thomas Walther; Robson A S Santos; Maria J Campagnole-Santos
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-05-11       Impact factor: 4.733

Review 7.  Are we poised to target ACE2 for the next generation of antihypertensives?

Authors:  Anderson J Ferreira; Mohan K Raizada
Journal:  J Mol Med (Berl)       Date:  2008-05-01       Impact factor: 4.599

8.  Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents.

Authors:  José A Hernández Prada; Anderson J Ferreira; Michael J Katovich; Vinayak Shenoy; Yanfei Qi; Robson A S Santos; Ronald K Castellano; Andrew J Lampkins; Vladimir Gubala; David A Ostrov; Mohan K Raizada
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

9.  Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation.

Authors:  Yumei Feng; Xinping Yue; Huijing Xia; Sharell M Bindom; Peter J Hickman; Catalin M Filipeanu; Guangyu Wu; Eric Lazartigues
Journal:  Circ Res       Date:  2008-02-07       Impact factor: 17.367

Review 10.  Angiotensin-converting enzyme 2 in the brain: properties and future directions.

Authors:  Huijing Xia; Eric Lazartigues
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

View more
  15 in total

Review 1.  Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.

Authors:  Jasenka Zubcevic; Monica M Santisteban; Teresa Pitts; David M Baekey; Pablo D Perez; Donald C Bolser; Marcelo Febo; Mohan K Raizada
Journal:  Hypertension       Date:  2014-03-31       Impact factor: 10.190

2.  Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction.

Authors:  Tatiane M Murça; Tatiane C S Almeida; Mohan K Raizada; Anderson J Ferreira
Journal:  Exp Physiol       Date:  2012-01-27       Impact factor: 2.969

3.  Development of obesity can be prevented in rats by chronic icv infusions of AngII but less by Ang(1-7).

Authors:  Martina Winkler; Michael Bader; Franziska Schuster; Ines Stölting; Sonja Binder; Walter Raasch
Journal:  Pflugers Arch       Date:  2018-02-11       Impact factor: 3.657

Review 4.  Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control.

Authors:  Annette D de Kloet; Meng Liu; Vermalí Rodríguez; Eric G Krause; Colin Sumners
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-17       Impact factor: 3.619

5.  Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress.

Authors:  Huijing Xia; Thyago Moreira de Queiroz; Srinivas Sriramula; Yumei Feng; Tanya Johnson; Imran N Mungrue; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-12-17       Impact factor: 3.619

Review 6.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

Review 7.  ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.

Authors:  Colleen T Cole-Jeffrey; Meng Liu; Michael J Katovich; Mohan K Raizada; Vinayak Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2015-12       Impact factor: 3.105

8.  Angiotensin-converting enzyme 2: the first decade.

Authors:  Nicola E Clarke; Anthony J Turner
Journal:  Int J Hypertens       Date:  2011-11-10       Impact factor: 2.420

9.  Angiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats.

Authors:  Ying Han; Hai-Jian Sun; Peng Li; Qing Gao; Ye-bo Zhou; Feng Zhang; Xing-Ya Gao; Guo-Qing Zhu
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

Review 10.  Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.

Authors:  Ewa Szczepanska-Sadowska; Katarzyna Czarzasta; Agnieszka Cudnoch-Jedrzejewska
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.